Toggle navigation
World Precision Medicine Congress USA 2017
7 - 8 November
Capital Hilton,
Washington DC
home
our story
attendees
agenda
2017 speakers
Conference Agenda Day One
Conference Agenda Day Two
sponsor
partners
networking
marketing opportunities
sponsorship opportunities
register
tickets & pricing
more
enquiry
contact us
venue
Eric Michael David
|
Chief Strategy Officer and Executive Vice President of Preclinical Development
Organovo
Appearances:
Day Two @ 11:40
Tissue-based cell therapy: a new route for precision med manufacturing
Delivering functional, architectural tissue to replace or augment organ function
Permitting delivery of gene therapy / iPSC / CART modified cells to solid organ targets
Providing a highly reproducible, automated way to enable tissue engraftment and vascularization into target organs
Eric Michael David,
Chief Strategy Officer and Executive Vice President of Preclinical Development,
Organovo
back to speakers
Organiser
© Terrapinn Holdings Ltd. MMXIV
privacy
t&c's
contact
subscription preferences
brochure